AnTolRx, Inc.
PrivateLast Round
Series A
Sep 8, 2016
Total Funding Raised
$4M
Company Overview
AnTolRx, Inc. is a biotechnology company that develops novel nanoformulation-based therapies designed to treat autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnTolRx, Inc. Comparables
Compare AnTolRx, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Integrated Nanotherapeutics | 90% | |
| Anokion | 86% | |
| Cour Pharma | 85% | |
AnTolRx, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 8, 2016 |
AnTolRx, Inc. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 8, 2016
$4M round led by Pfizer and JDRF.
AnTolRx, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AnTolRx, Inc.'s valuation, stock price, and market status.